Galectin Therapeutics Reports Third Quarter 2014 Financial Results and Provides Update on Company's Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. IBM
5. META
6. MU
7. BLZE
8. PRIM
9. ACN
10. NVDA

Go back to Galectin Therapeutics Reports Third Quarter 2014 Financial Results and Provides Update on Company's Development Program
GALECTIN (NASDAQ: GALT) Delayed: 3.12 +0.32 (11.43%)
Previous Close $2.80    52 Week High $3.05 
Open $2.71    52 Week Low $0.49 
Day High $3.70    P/E N/A 
Day Low $2.71    EPS $-1.32 
Volume 3,792,827